Kesmalea Therapeutics
Developer of a pipeline of therapeutics designed to transform large protein degraders into small molecules for targeted protein degradation. The company's platform enables the creation of oral, CNS-pe...
Valuation
$39M
Market implied
Share Price
N/A
Total Raised
$37.8M
Last Round
N/A